European secondaries boom unlikely to end soon
The rise of global secondaries transactions, estimated to reach an aggregate value of between €25-30bn this year, up from €20bn in 2010 and €25bn in 2011, seems set to continue.
More on Secondaries
Equistone considers moving Sicame to continuation fund
GP is also studying a potential refinancing of the French electricity distribution products and services provider
Ufenau moves Corius and Altano to continuation fund
Bought in 2017, the dermatology and vet groups have been transferred into the Swiss GP’s third continuation vehicle
GED completes Vitro exit in single asset vehicle deal
GP reaps gross return of 4.0x invested capital and 38% IRR; deal follows sale of Vitro subsidiary to trade in January
EQT sells WS Audiology to new fund
EQT VIII and Santos Holding will buy the company from EQT VI
Latest News
Verdane scores 5x MOIC in partial exit of Inriver to THL
Majority investment from THL Partners sees Verdane retain a minority stake in the Swedish company
CVC to buy sports nutrition specialist The Quality Group
GP to acquire majority stake via Fund VIII; German group’s founders to reinvest in the deal
DBAG to target EUR 1.3bn-EUR 1.5bn for new buyout fund next year
German GP’s new vehicle will be slightly larger than its predecessor, which is set to complete deployment in two years
Alcedo heads for June final close for Fund V
Italian GP has received EUR 230m in commitments to date for Fund V against a EUR 250m hard-cap